YD Bio Limited Ordinary Shares
YDES | NASDAQ
$2.63
-$0.56 (-17.55%)
At close: Sep 21, 2026, 4:00 PM ET
$2.74
+$0.11 (+4.18%)
Pre-market:
Sep 22, 2026, 4:24 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 596.82K | 510.36K | 350.13K | n/a | n/a | n/a |
Cost of Revenue | 638.97K | 355K | 196.69K | n/a | n/a | n/a |
Gross Profit | -42.15K | 155.36K | 153.45K | n/a | n/a | n/a |
Operating Income | -5.27M | -1.46M | -9.85K | -2.32M | -1.72M | -344.22K |
Interest Income | 80.16K | 11.81K | 290 | 813 | 764 | 178 |
Pretax Income | -8.31M | -1.39M | 17.65K | 3.79M | 8.7M | -2.54M |
Net Income | -8.31M | -1.41M | 13.56K | 3.79M | 8.7M | -2.54M |
Selling & General & Admin | 3.63M | 1.13M | 160.56K | 2.32M | 1.72M | 344.22K |
Research & Development | 1.6M | 491.35K | n/a | n/a | n/a | n/a |
Other Expenses | n/a | -493 | 2.73K | n/a | n/a | n/a |
Operating Expenses | 5.23M | 1.62M | 163.29K | 2.32M | 1.72M | 344.22K |
Interest Expense | n/a | 772 | 2.14K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 1.96K | 7.49K | n/a | n/a | n/a |
Cost & Expenses | 5.87M | 1.97M | 359.98K | 2.32M | 1.72M | 344.22K |
Income Tax Expense | -1.53K | 25.08K | 4.09K | 2.09K | n/a | n/a |
Shares Outstanding (Basic) | 66.72M | 4.15M | 70.1M | 9.29M | 14.63M | 14.63M |
Shares Outstanding (Diluted) | 66.72M | 4.15M | 70.1M | 9.29M | 14.63M | 14.63M |
EPS (Basic) | -0.12 | -0.56 | 0 | 0.41 | 0.59 | -0.17 |
EPS (Diluted) | -0.12 | -0.56 | 0 | 0.41 | 0.59 | -0.17 |
EBITDA | -5.06M | -1.28M | 22.25K | 3.79M | 8.7M | -2.54M |
EBIT | -5.27M | -1.39M | 19.79K | 3.79M | 8.7M | -2.54M |
Depreciation & Amortization | 209.56K | 104.74K | 2.45K | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove YDES